Items where Author is "Endlicher, E."

Article

Walter, I. and Schulz, U. and Vogelhuber, M. and Wiedmann, K. and Endlicher, E. and Klebl, F. and Andreesen, R. and Herr, W. and Ghibelli, L. and Hackl, C. and Wiest, R. and Reichle, A. (2017) Communicative reprogramming non-curative hepatocellular carcinoma with low-dose metronomic chemotherapy, COX-2 inhibitor and PPAR-gamma agonist: a phase II trial. MEDICAL ONCOLOGY, 34 (12): 192. ISSN 1357-0560, 1559-131X

Bentz, S. and Cee, A. and Endlicher, E. and Wojtal, K. A. and Naami, A. and Pesch, T. and Lang, S. and Schubert, P. and Fried, M. and Weber, A. and Coy, J. F. and Goelder, S. and Knuechel, R. and Hausmann, M. and Rogler, G. (2013) Hypoxia Induces the Expression of Transketolase-Like 1 in Human Colorectal Cancer. DIGESTION, 88 (3). pp. 182-192. ISSN 0012-2823, 1421-9867

Fensterer, H. and Schade-Brittinger, C. and Mueller, H. -H. and Tebbe, S. and Fass, J. and Lindig, U. and Settmacher, U. and Schmidt, W. E. and Maerten, A. and Ebert, M. P. and Kornmann, M. and Hofheinz, R. and Endlicher, E. and Brendel, C. and Barth, P. J. and Bartsch, D. K. and Michl, P. and Gress, T. M. (2013) Multicenter phase II trial to investigate safety and efficacy of gemcitabine combined with cetuximab as adjuvant therapy in pancreatic cancer (ATIP). ANNALS OF ONCOLOGY, 24 (10). pp. 2576-2581. ISSN 0923-7534

Harder, J. and Ihorst, G. and Heinemann, V. and Hofheinz, R. and Moehler, M. and Buechler, P. and Kloeppel, G. and Roecken, C. and Bitzer, M. and Boeck, S. and Endlicher, E. and Reinacher-Schick, A. and Schmoor, C. and Geissler, M. (2012) Multicentre phase II trial of trastuzumab and capecitabine in patients with HER2 overexpressing metastatic pancreatic cancer. BRITISH JOURNAL OF CANCER, 106 (6). pp. 1033-1038. ISSN 0007-0920

Kullmann, Frank and Hartmann, A. and Stoehr, R. and Messmann, H. and Dollinger, M. M. and Trojan, J. and Fuchs, M. and Hollerbach, S. and Harder, J. and Troppmann, M. and Kutscheidt, A. and Endlicher, E. (2011) KRAS Mutation in Metastatic Pancreatic Ductal Adenocarcinoma: Results of a Multicenter Phase II Study Evaluating Efficacy of Cetuximab plus Gemcitabine/Oxaliplatin (GEMOXCET) in First-Line Therapy. ONCOLOGY, 81 (1). pp. 3-8. ISSN 0030-2414

Fensterer, H. and Schade-Brittinger, C. and Mueller, H. and Schupfner, B. and Fass, J. and Lindig, U. and Settmacher, U. and Ebert, M. P. and Kornmann, M. and Hofheinz, R. and Endlicher, E. and Brendel, C. and Barth, P. J. and Bartsch, D. K. and Gress, T. M. (2011) Multicenter phase II trial to investigate safety and efficacy of an adjuvant therapy with gemcitabine and cetuximab in patients with R0 or R1 resected pancreatic cancer. JOURNAL OF CLINICAL ONCOLOGY, 29 (15supp): 4039. ISSN 0732-183X, 1527-7755

Schlingensiepen, K. and Oettle, H. and Seufferlein, T. and Luger, T. and Schmid, R. M. and von Wichert, G. and Endlicher, E. and Garbe, C. and Kaehler, K. C. and Enk, A. (2011) Phase I/II Study With Trabedersen (AP 12009) Monotherapy for the Treatment of Patients With Advanced Pancreatic Cancer, Malignant Melanoma or Colorectal Carcinoma. EUROPEAN JOURNAL OF CANCER, 47 (Suppl1). S154. ISSN 0959-8049

Oettle, H. and Hilbig, A. and Seufferlein, T. and Tsianakas, A. and Luger, T. and Schmid, R. M. and von Wichert, G. and Endlicher, E. and Garbe, C. and Kaehler, K. K. and Hauschild, A. and Enk, A. and Kiessling, P. and Schmaus, S. and Heinrichs, H. and Schlingensiepen, K. (2011) Phase I/II study with trabedersen (AP 12009) monotherapy for the treatment of patients with advanced pancreatic cancer, malignant melanoma, and colorectal carcinoma. JOURNAL OF CLINICAL ONCOLOGY, 29 (15supp): 2513. ISSN 0732-183X, 1527-7755

Lordick, F. and Luber, B. and Lorenzen, S. and Hegewisch-Becker, S. and Folprecht, G. and Woell, E. and Decker, T. and Endlicher, E. and Roethling, N. and Schuster, T. and Keller, G. and Fend, F. and Peschel, C. (2010) Cetuximab plus oxaliplatin/leucovorin/5-fluorouracil in first-line metastatic gastric cancer: a phase II study of the Arbeitsgemeinschaft Internistische Onkologie (AIO). BRITISH JOURNAL OF CANCER, 102 (3). pp. 500-505. ISSN 0007-0920

Laffranchi, B. and De Jonge, M. J. and Bajetta, E. and Hendlisz, A. and Giuliani, R. and Barone, C. and Endlicher, E. and Jannuzzo, M. G. and Spinelli, R. and Santoro, A. (2010) Phase H study of danusertib (13) in advanced/metastatic colorectal and pancreatic cancers (CRC, PC). JOURNAL OF CLINICAL ONCOLOGY, 28 (15supp). ISSN 0732-183X, 1527-7755

Kullmann, F. and Hollerbach, S. and Dollinger, M. M. and Harder, J. and Fuchs, M. and Messmann, H. and Trojan, J. and Gaebele, E. and Hinke, A. and Hollerbach, C. and Endlicher, E. (2009) Cetuximab plus gemcitabine/oxaliplatin (GEMOXCET) in first-line metastatic pancreatic cancer: a multicentre phase II study. BRITISH JOURNAL OF CANCER, 100 (7). pp. 1032-1036. ISSN 0007-0920, 1532-1827

Lippert, E. and Endlicher, E. (2009) Hyperglycemia: A Risk Factor for Gastric Cancer Development? ZEITSCHRIFT FUR GASTROENTEROLOGIE, 47 (9). pp. 850-853. ISSN 0044-2771

Reichle, A. and Walpinski, S. and Vogelhuber, M. and Wiedmann, K. and Berand, A. and Endlicher, E. and Klebl, F. and Schoelmerich, J. and Andreesen, R. and Wiest, R. (2008) Targeted anti-inflammatory and angiostatic therapy in pretreated patients with advanced hepatocellular carcinoma. JOURNAL OF CLINICAL ONCOLOGY, 26 (15supp): 15560. ISSN 0732-183X

Kullmann, F. and Hollerbach, S. and Fuchs, M. and Messmann, H. and Dollinger, M. M. and Trojan, J. and Harder, J. and Gaebele, E. and Hinke, A. and Endlicher, E. (2007) Cetuximab plus gemcitabine/oxaliplatin (GEMOXCET) in 1st line metastatic pancreatic cancer - a multicenter phase II study. EJC SUPPLEMENTS, 5 (4). p. 269. ISSN 1359-6349

Lordick, F. and Lorenzen, S. and Hegewisch-Becker, S. and Folprecht, G. and Woell, E. and Decker, T. and Endlicher, E. and Roethling, N. and Fend, F. and Peschel, C. (2007) Cetuximab plus weekly oxaliplatin/5FU/FA (FUFOX) in 1st line metastatic gastric cancer. Final results from a multicenter phase II study of the AIO upper GI study group. JOURNAL OF CLINICAL ONCOLOGY, 25 (18supp): 4526. ISSN 0732-183X, 1527-7755

Endlicher, E. and Troppmann, M. and Kullmann, A. and Goelder, S. and Herold, T. and Herfarth, H. and Grossmann, J. and Schlottmann, K. and Kullmann, Frank (2007) Irinotecan plus gemcitabine and 5-fluorouracil in advanced pancreatic cancer: A phase II study. ONCOLOGY, 72 (5-6). pp. 279-284. ISSN 0030-2414

Ott, C. and Ratiu, N. and Endlicher, E. and Rath, H. C. and Gelbmann, C. M. and Schoelmerich, J. and Kullmann, F. (2007) Self-expanding Polyflex plastic stents in esophageal disease: various indications, complications, and outcomes. SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 21 (6). pp. 889-896. ISSN 0930-2794, 1432-2218

Klebl, F. and Endlicher, E. and Kullmann, F. (2006) Palliative therapy in cholangio- and gallbladder carcinoma. ZEITSCHRIFT FUR GASTROENTEROLOGIE, 44 (7). pp. 587-598. ISSN 0044-2771, 1439-7803

Endlicher, E. and Gelbmann, C. and Schlottmann, K. and Herfarth, H. and Ruemmele, P. and Friedrich, A. and Schoelmerich, Juergen and Kullmann, Frank (2004) Endoscopic mucosal resection for early esophageal cancer with esophageal varices. ZEITSCHRIFT FUR GASTROENTEROLOGIE, 42 (7). pp. 609-613. ISSN 0044-2771, 1439-7803

Messmann, Helmut and Endlicher, E. and Freunek, G. and Ruemmele, P. and Schoelmerich, Juergen and Knuechel, R. (2003) Fluorescence endoscopy for the detection of low and high grade dysplasia in ulcerative colitis using systemic or local 5-aminolaevulinic acid sensitisation. GUT, 52 (7). pp. 1003-1007. ISSN 0017-5749

Messmann, Helmut and Endlicher, E. and Gelbmann, C. M. and Schoelmerich, Juergen (2002) Fluorescence endoscopy and photodynamic therapy. DIGESTIVE AND LIVER DISEASE, 34 (10). pp. 754-761. ISSN 1590-8658, 1878-3562

Krieg, R. C. and Uihlein, D. and Murthum, T. and Endlicher, E. and Hausmann, F. and Messmann, H. and Knuechel, Ruth (2002) Improving the use of 5-aminolevulinic acid (ALA)-induced protoporphyrin IX (PPIX) for the gastrointestinal tract by esterification - An in vitro study. CELLULAR AND MOLECULAR BIOLOGY, 48 (8). pp. 917-923. ISSN 0145-5680

Endlicher, E. and Ruemmele, Petra and Hausmann, F. and Krieg, R. and Knuechel, Ruth and Rath, H. and Schoelmerich, Juergen and Messmann, Helmut (2001) Protoporphyrin IX distribution following local application of 5-aminolevulinic acid and its esterified derivatives in the tissue layers of the normal rat colon. BRITISH JOURNAL OF CANCER, 85 (10). pp. 1572-1576. ISSN 0007-0920

Brunner, Henri and Hausmann, F. and Krieg, R. C. and Endlicher, E. and Schoelmerich, Juergen and Knuechel, R. and Messmann, H. (2001) The effects of 5-aminolevulinic acid esters on protoporphyrin IX production in human adenocarcinoma cell lines. PHOTOCHEMISTRY AND PHOTOBIOLOGY, 74 (5). pp. 721-725. ISSN 0031-8655